Previous close | 10,946.00 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 2,835,612 |
Market cap | 174.4B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 36.53 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (2.02%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
Key Insights Given the large stake in the stock by institutions, AstraZeneca's stock price might be vulnerable to their...
Beyond analysts' top -and-bottom-line estimates for Astrazeneca (AZN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]